Active, not recruitingPHASE1, PHASE2NCT06211634
A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
Studying Glanzmann thrombasthenia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hemab ApS
- Intervention
- HMB-001(drug)
- Enrollment
- 57 enrolled
- Eligibility
- 18-67 years · All sexes
- Timeline
- 2022 – 2027
Study locations (17)
- University of California, San Diego (UCSD) (Part B/C), La Jolla, California, United States
- Tulane University Medical Center (Part B/C), New Orleans, Louisiana, United States
- Mayo Clinic - Rochester (Part B/C), Rochester, Minnesota, United States
- Hemophilia Center of Western Pennsylvania (HCWP) (Part B/C), Pittsburgh, Pennsylvania, United States
- Washington Institute for Coagulation (Part B/C), Seattle, Washington, United States
- University Hospital Leuven - Campus Gasthuisberg (Part B/C), Leuven, Belgium
- AP-HP Hopital Bicetre (Part B/C), Le Kremlin-Bicêtre, France
- AP-HM - Hopital de la Timone, Marseille, France
- AP-HP Hopital Necker-Enfants Malades (Part B/C), Paris, France
- Azienda Ospedaliero-Universitaria Careggi (Part B/C), Florence, Italy
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano (Part B/C), Milan, Italy
- Universitair Medisch Centrum Utrecht (Part B/C), Utrecht, Netherlands
- Queen Elizabeth Hospital Birmingham (Part B/C), Birmingham, United Kingdom
- Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
- Richmond Pharmacology Ltd (Part A/B/C), London, United Kingdom
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06211634 on ClinicalTrials.govOther trials for Glanzmann thrombasthenia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07136857Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)Emory University
- RECRUITINGNCT06820515ATHNdataset RegistryAmerican Thrombosis and Hemostasis Network
- RECRUITINGNANCT04119908Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic DiseasesUniversity Hospital, Lille
- RECRUITINGNCT00230165The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.Rockefeller University